Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 2
1956 1
1988 1
1989 3
1991 1
1994 2
1997 2
1998 1
1999 2
2000 5
2001 4
2002 6
2003 14
2004 7
2005 12
2006 10
2007 12
2008 11
2009 13
2010 14
2011 8
2012 16
2013 7
2014 10
2015 3
2016 7
2017 13
2018 13
2019 10
2020 20
2021 13
2022 13
2023 17
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

263 results

Results by year

Filters applied: . Clear all
Page 1
Barriers and Motivators to Engage in Exercise for Persons with Parkinson's Disease.
Schootemeijer S, van der Kolk NM, Ellis T, Mirelman A, Nieuwboer A, Nieuwhof F, Schwarzschild MA, de Vries NM, Bloem BR. Schootemeijer S, et al. Among authors: schwarzschild ma. J Parkinsons Dis. 2020;10(4):1293-1299. doi: 10.3233/JPD-202247. J Parkinsons Dis. 2020. PMID: 32925106 Free PMC article. Review.
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial.
Parkinson Study Group SURE-PD3 Investigators; Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB Jr, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T. Parkinson Study Group SURE-PD3 Investigators, et al. Among authors: schwarzschild ma. JAMA. 2021 Sep 14;326(10):926-939. doi: 10.1001/jama.2021.10207. JAMA. 2021. PMID: 34519802 Free PMC article. Clinical Trial.
Lifestyle and Parkinson's disease progression.
Ascherio A, Schwarzschild MA. Ascherio A, et al. Among authors: schwarzschild ma. Mov Disord. 2019 Jan;34(1):7-8. doi: 10.1002/mds.27566. Mov Disord. 2019. PMID: 30653733 No abstract available.
Dietary antioxidants and Parkinson's disease.
Ascherio A, Schwarzschild MA. Ascherio A, et al. Among authors: schwarzschild ma. Mov Disord. 2017 Nov;32(11):1501-1503. doi: 10.1002/mds.27194. Epub 2017 Oct 4. Mov Disord. 2017. PMID: 28976040 No abstract available.
Path to Parkinson Disease Prevention: Conclusion and Outlook.
Berg D, Crotty GF, Keavney JL, Schwarzschild MA, Simuni T, Tanner C. Berg D, et al. Among authors: schwarzschild ma. Neurology. 2022 Aug 16;99(7 Suppl 1):76-83. doi: 10.1212/WNL.0000000000200793. Neurology. 2022. PMID: 35970586 Review.
Mitochondrial haplogroups and cognitive progression in Parkinson's disease.
Liu G, Ni C, Zhan J, Li W, Luo J, Liao Z, Locascio JJ, Xian W, Chen L, Pei Z, Corvol JC, Maple-Grødem J, Campbell MC, Elbaz A, Lesage S, Brice A, Hung AY, Schwarzschild MA, Hayes MT, Wills AM, Ravina B, Shoulson I, Taba P, Kõks S, Beach TG, Cormier-Dequaire F, Alves G, Tysnes OB, Perlmutter JS, Heutink P, van Hilten JJ, Barker RA, Williams-Gray CH, Scherzer CR; International Genetics of Parkinson Disease Progression (IGPP) Consortium. Liu G, et al. Among authors: schwarzschild ma. Brain. 2023 Jan 5;146(1):42-49. doi: 10.1093/brain/awac327. Brain. 2023. PMID: 36343661 Free PMC article.
Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, McKee KE, Goelz L, Poon C, Tilley B, Kang UJ, Tansey MG, Luthra N, Tanner CM, Haus JM, Fantuzzi G, McFarland NR, Gonzalez-Latapi P, Foroud T, Motl R, Schwarzschild MA, Simuni T, Marek K, Naito A, Lungu C, Corcos DM; SPARX3-PSG Investigators. Patterson CG, et al. Among authors: schwarzschild ma. Trials. 2022 Oct 6;23(1):855. doi: 10.1186/s13063-022-06703-0. Trials. 2022. PMID: 36203214 Free PMC article.
Seeking progress in disease modification in Parkinson disease.
Lungu C, Cedarbaum JM, Dawson TM, Dorsey ER, Faraco C, Federoff HJ, Fiske B, Fox R, Goldfine AM, Kieburtz K, Macklin EA, Matthews H, Rafaloff G, Saunders-Pullman R, Schor NF, Schwarzschild MA, Sieber BA, Simuni T, Surmeier DJ, Tamiz A, Werner MH, Wright CB, Wyse R. Lungu C, et al. Among authors: schwarzschild ma. Parkinsonism Relat Disord. 2021 Sep;90:134-141. doi: 10.1016/j.parkreldis.2021.09.006. Epub 2021 Sep 10. Parkinsonism Relat Disord. 2021. PMID: 34561166 Review.
263 results